Agenus | AGEN - Capitale Ordinario





Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 1.75B 2025-06
Agenus USD 38.52M 3.2M 2026-03
Amgen USD 541M 1000K 2026-06
AstraZeneca USD 1.55B 44K 2026-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Celldex Therapeutics USD 78.5M 11.93M 2026-06
CSL USD 482.13M 93.87M 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
Glaxosmithkline GBP 4.05B 20.6M 2026-03
Incyte USD 200.98M 1.03M 2026-06
Intrexon USD 0 0 2024-06
J&J USD 2.41B 1.35M 2026-03
Jiangsu Hengrui CNY 6.64B 0 2026-06
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
MacroGenics USD 63.56M 241K 2026-03
Merck EUR 434.78M 0 2026-06
Merck USD 2.47B 4.93M 2026-03
Northwest Biotherapeutics USD 1.61B 88.6M 2026-03
Novartis USD 1.9B 7.38M 2026-06
Novavax USD 162.58M 106K 2025-12
Pfizer USD 5.7B 0 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Rigel Pharmaceuticals USD 17K 158K 2024-06
Veracyte USD 79.79M 1000 2026-06